Haleon Us Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HALEON US HOLDINGS, and when can generic versions of HALEON US HOLDINGS drugs launch?
HALEON US HOLDINGS has thirty-one approved drugs.
There are ten US patents protecting HALEON US HOLDINGS drugs.
There are two hundred and three patent family members on HALEON US HOLDINGS drugs in thirty-two countries and sixteen supplementary protection certificates in eight countries.
Summary for Haleon Us Holdings
International Patents: | 203 |
US Patents: | 10 |
Tradenames: | 28 |
Ingredients: | 18 |
NDAs: | 31 |
Drugs and US Patents for Haleon Us Holdings
Expired US Patents for Haleon Us Holdings
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | CHILDREN'S ADVIL ALLERGY SINUS | chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride | SUSPENSION;ORAL | 021587-001 | Feb 24, 2004 | 10,238,640 | ⤷ Free Trial |
Haleon Us Holdings | ADVIL PM | diphenhydramine citrate; ibuprofen | TABLET;ORAL | 021394-001 | Dec 21, 2005 | 8,263,647 | ⤷ Free Trial |
Haleon Us Holdings | ADVIL COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | CAPSULE;ORAL | 021374-001 | May 30, 2002 | 5,071,643*PED | ⤷ Free Trial |
Haleon Us Holdings | ABREVA | docosanol | CREAM;TOPICAL | 020941-001 | Jul 25, 2000 | 5,534,554 | ⤷ Free Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HALEON US HOLDINGS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 200 mg/30 mg | ➤ Subscribe | 2004-12-27 |
➤ Subscribe | Capsules | 60 mg | ➤ Subscribe | 2010-09-08 |
➤ Subscribe | Gum | 4 mg | ➤ Subscribe | 2013-01-22 |
➤ Subscribe | Capsules | 200 mg/38 mg | ➤ Subscribe | 2016-02-16 |
➤ Subscribe | Gum | 2 mg | ➤ Subscribe | 2013-01-22 |
International Patents for Haleon Us Holdings Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2011015972 | ⤷ Free Trial |
Canada | 2508611 | ⤷ Free Trial |
Taiwan | 200609004 | ⤷ Free Trial |
Russian Federation | 2005122403 | ⤷ Free Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Haleon Us Holdings Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1519731 | 13C0067 | France | ⤷ Free Trial | PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215 |
1519731 | 92269 | Luxembourg | ⤷ Free Trial | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
2506844 | 132018000000341 | Italy | ⤷ Free Trial | PRODUCT NAME: UN PRODOTTO DI COMBINAZIONE FARMACEUTICA COMPRENDENTE UN SALE FARMACEUTICAMENTE ACCETTABILE DI UMECLIDINIO (AD ESEMPIO BROMURO DI UMECLIDINIO), VILANTEROLO O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE (AD ESEMPIO VILANTEROLO TRIFENATATO) E UN FUROATO(TRELEGY ELLIPTA - FLUTICASONE FUROATO/UMECLIDINIO/VILANTEROLO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1236, 20171117 |
1519731 | 132013902182575 | Italy | ⤷ Free Trial | PRODUCT NAME: AZELASTINA CLORIDRATO/FLUTICASONE PROPIONATO(DYMISTA); AUTHORISATION NUMBER(S) AND DATE(S): 2011/07125-REG, 20111024;041808015/M-027/M-039/M-041/M, 20130527 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.